Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Dagnon Terry
Chief Operations Officer at Outlook Therapeutics. Filing since 12 Feb 2021.
CIK 0001760510
Company
Date
Role
Action
Shares
Amount
Of holding
OTLK
Outlook Therapeutics, Inc.
20 Apr 2023
Chief Operations Officer
Sold at will
520,000
$590.20K
44.3%
OTLK
Outlook Therapeutics, Inc.
21 Jun 2022
Chief Operating Officer
Bought
10,000
$10.50K
0.9%
OTLK
Outlook Therapeutics, Inc.
6 Dec 2021
Chief Operating Officer
Bought
25,201
$34.78K
2.2%
OTLK
Outlook Therapeutics, Inc.
3 Dec 2021
Chief Operating Officer
Bought
10,000
$14.20K
0.9%
OTLK
Outlook Therapeutics, Inc.
23 Feb 2021
Chief Operating Officer
Sold, plan not stated
15,900
$33.20K
1.4%
OTLK
Outlook Therapeutics, Inc.
12 Feb 2021
Chief Operating Officer
Sold, plan not stated
63,700
$162.44K
5.3%
6 decisions on file.